The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Animal models of nonalcoholic fatty liver disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Furthermore, given the growing number of individuals who are overweight or obese in the USA (currently >60”
BackgroundObesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“Concomitantly, there is an increase in the number and activation status of adipose-infiltrating macrophages that potentiates further inflammation”
BackgroundNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Increased JNK activity can promote insulin resistance, and JNK1 −/− mice have decreased adiposity, improved insulin sensitivity and enhanced insulin receptor signaling during obesity”
BackgroundNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145 · cited 1×
“Studies have also shown that anti-inflammatory regulatory T cells are lost from lean fat and that CD8 + effector T cells promote macrophage recruitment and adipose inflammation as obesity develops”
BackgroundMetabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 1×
“Moreover, mice that lack IL-6 or TNF receptor 1 (TNFR1) have reduced levels of hepatic lipid and macrophage and neutrophil infiltration when fed a high-fat diet, resulting in the prevention of steatohepatitis”
BackgroundObesity and the role of adipose tissue in inflammation and metabolism
Greenberg, A. S., & Obin, M. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.461s · Cited by 1,273
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., & Diehl, A. M. (2010) · Hepatology · doi:10.1002/hep.23535 · Cited by 770
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Toll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722 · cited 1×
“TLRs recognize these bacterial products and activate interferon (IFN)-α/β, NFκB and activator protein 1 (AP1) proinflammatory responses”
BackgroundMouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714
Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype
Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., Pedersen, A. A., Kalthoff, C., Tullin, S., Sams, A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088708 · Cited by 646
Variation in susceptibility to atherosclerosis among inbred strains of mice
PAIGEN, B., MORROW, A., BRANDON, C., MITCHELL, D., & HOLMES, P. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90138-8 · Cited by 612
He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 610
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.075 · Cited by 592 · cited 1×
“This is concordant with human data showing that progressive increases in intrahepatic triglycerides are associated with the gradual reduction of insulin sensitivity in the liver, skeletal muscle and adipose tissues of nondiabetic, obese individuals”
ResultToll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 549
Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L. (1990) · Science · doi:10.1126/science.2167514 · Cited by 539
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Matsuzawa, N., Takamura, T., Kurita, S., Misu, H., Ota, T., Ando, H., Yokoyama, M., Honda, M., Zen, Y., Nakanuma, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21874 · Cited by 515
Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity
Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., & Walsh, K. (2010) · Science · doi:10.1126/science.1188280 · Cited by 490
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.029 · Cited by 479
Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice
Ip, E., Farrell, G. C., Robertson, G., Hall, P., Kirsch, R., & Leclercq, I. (2003) · Hepatology · doi:10.1053/jhep.2003.50307 · Cited by 476
Wouters, K., van Gorp, P. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lütjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., et al. (2008) · Hepatology · doi:10.1002/hep.22363 · Cited by 476
Rinella, M. E., & Green, R. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.020 · Cited by 460
Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet
Rinella, M. E., Elias, M. S., Smolak, R. R., Fu, T., Borensztajn, J., & Green, R. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800042-jlr200 · Cited by 451
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.003 · Cited by 425
Model of nonalcoholic steatohepatitis
Lieber, C. S., Leo, M. A., Mak, K. M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A., & DeCarli, L. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.502 · Cited by 424
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403
Weltman, M., Farrell, G., & Liddle, C. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70028-8 · Cited by 397
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384 · cited 1×
“Nevertheless, studies have shown that the MCD diet does reduce hepatic insulin sensitivity through the action of oxidative stress and c-Jun N-terminal kinase (JNK) activation to suppress insulin receptor activity”
BackgroundIp, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378
Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis
Alkhouri, N., Gornicka, A., Berk, M. P., Thapaliya, S., Dixon, L. J., Kashyap, S., Schauer, P. R., & Feldstein, A. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074252 · Cited by 369
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 1×
“For example, mice with muscle-specific insulin receptor inactivation develop obesity and have increased levels of plasma triglycerides, analogous to insulin-resistant humans (who have an increased risk of developing fatty liver disease over their lifetime)”
BackgroundDiagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
Wieckowska, A., & Feldstein, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091983 · Cited by 300
dela Peña, A., Leclercq, I., Field, J., George, J., Jones, B., & Farrell, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.004 · Cited by 287
Self-citationVeldt, B. J., Chen, W., Heathcote, J. E., Wedemeyer, H., Reichen, J., Hofmann, P. W., de Knegt, R. J., Zeuzem, S., Manns, M. P., Hansen, B. E., et al. (2008) · Hepatology · doi:10.1002/hep.22251 · Cited by 284
Pan, M., Cederbaum, A. I., Zhang, Y.-L., Ginsberg, H. N., Williams, K. J., & Fisher, E. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19197 · Cited by 279
Velayudham, A., Dolganiuc, A., Ellis, M., Petrasek, J., Kodys, K., Mandrekar, P., & Szabo, G. (2009) · Hepatology · doi:10.1002/hep.22711 · Cited by 263
Chen, W., Chang, B., Li, L., & Chan, L. (2010) · Hepatology · doi:10.1002/hep.23812 · Cited by 247
George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., & Farrell, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00376-3 · Cited by 247
Self-citationLi, T., Owsley, E., Matozel, M., Hsu, P., Novak, C. M., & Chiang, J. Y. L. (2010) · Hepatology · doi:10.1002/hep.23721 · Cited by 245
Shiri-Sverdlov, R., Wouters, K., Gorp, P. J. V., Gijbels, M. J., Noel, B., Buffat, L., Staels, B., Maeda, N., Bilsen, M. V., & Hofker, M. H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.033 · Cited by 241
High-fat emulsion-induced rat model of nonalcoholic steatohepatitis
Zou, Y., Li, J., Lu, C., Wang, J., Ge, J., Huang, Y., Zhang, L., & Wang, Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.03.021 · Cited by 239
Nagasawa, T., Inada, Y., Nakano, S., Tamura, T., Takahashi, T., Maruyama, K., Yamazaki, Y., Kuroda, J., & Shibata, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.028 · Cited by 233
Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
Leclercq, I. A., Farrell, G. C., Sempoux, C., Peña, A. D., & Horsmans, Y. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.010 · Cited by 224
Recent advances in nonalcoholic fatty liver disease
Cheung, O., & Sanyal, A. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283294a18 · Cited by 219
Steatohepatitis Induced by Intragastric Overfeeding in Mice *
Deng, Q.-G., She, H., Cheng, J. H., French, S. W., Koop, D. R., Xiong, S., & Tsukamoto, H. (2005) · Hepatology · doi:10.1002/hep.20877 · Cited by 215
Morphology of Alcoholic Liver Disease
Lefkowitch, J. H. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.11.001 · Cited by 212
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 210
Vergnes, L., Phan, J., Strauss, M., Tafuri, S., & Reue, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306022200 · Cited by 203
Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195
Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M., & Czaja, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410310200 · Cited by 194 · cited 1×
“Nevertheless, studies have shown that the MCD diet does reduce hepatic insulin sensitivity through the action of oxidative stress and c-Jun N-terminal kinase (JNK) activation to suppress insulin receptor activity”
BackgroundWada, T., Kenmochi, H., Miyashita, Y., Sasaki, M., Ojima, M., Sasahara, M., Koya, D., Tsuneki, H., & Sasaoka, T. (2010) · Endocrinology · doi:10.1210/en.2009-0869 · Cited by 189
Non‐alcoholic steatohepatitis: Definitions and pathogenesis
DAY, C., & SAKSENA, S. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.31.x · Cited by 185
ALCOHOLIC LIVER DISEASE: MORPHOLOGICAL MANIFESTATIONS
An International Group (1981) · The Lancet · doi:10.1016/s0140-6736(81)91984-x · Cited by 184
Kamada, Y., Matsumoto, H., Tamura, S., Fukushima, J., Kiso, S., Fukui, K., Igura, T., Maeda, N., Kihara, S., Funahashi, T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.020 · Cited by 183
Histopathology of Non-Alcoholic Fatty Liver Disease
Brunt, E. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.008 · Cited by 172
Yu, J., Ip, E., dela Peña, A., Hou, J. Y., Sesha, J., Pera, N., Hall, P., Kirsch, R., Leclercq, I., & Farrell, G. C. (2006) · Hepatology · doi:10.1002/hep.21108 · Cited by 169
Recent advances in nonalcoholic fatty liver disease
Cheung, O., & Sanyal, A. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328337b0c4 · Cited by 163
Wueest, S., Rapold, R. A., Schumann, D. M., Rytka, J. M., Schildknecht, A., Nov, O., Chervonsky, A. V., Rudich, A., Schoenle, E. J., Donath, M. Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38388 · Cited by 162
Bieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lütjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.051 · Cited by 160
Larter, C. Z., Yeh, M. M., Williams, J., Bell-Anderson, K. S., & Farrell, G. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.026 · Cited by 145
Mallory body—A disease-associated type of sequestosome
Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K., & Denk, H. (2002) · Hepatology · doi:10.1053/jhep.2002.32674 · Cited by 135
Baumgardner, J. N., Shankar, K., Hennings, L. J., Badger, T. M., & Ronis, M. J. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00296.2007 · Cited by 131
Jornayvaz, F. R., Samuel, V. T., & Shulman, G. I. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104726 · Cited by 126
Wunderlich, F. T., Luedde, T., Singer, S., Schmidt‐Supprian, M., Baumgartl, J., Schirmacher, P., Pasparakis, M., & Brüning, J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707849104 · Cited by 123
Tomita, K., Oike, Y., Teratani, T., Taguchi, T., Noguchi, M., Suzuki, T., Mizutani, A., Yokoyama, H., Irie, R., Sumimoto, H., et al. (2008) · Hepatology · doi:10.1002/hep.22365 · Cited by 121
Pathogenesis of NASH: Animal Models
London, R. M., & George, J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.010 · Cited by 117
Self-citationAlcoholic liver disease: morphological manifestations. Review by an international group.
(1981) · PubMed · Cited by 112
Obara, N., Fukushima, K., Ueno, Y., Wakui, Y., Kimura, O. S., Tamai, K., Kakazu, E., Inoue, J., Kondo, Y., Ogawa, N., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.029 · Cited by 111
Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
Asano, T., Watanabe, K., Kubota, N., Gunji, T., Omata, M., Kadowaki, T., & Ohnishi, S. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06039.x · Cited by 104
Leclercq, I. A., Lebrun, V. A., Stärkel, P., & Horsmans, Y. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700489 · Cited by 100
Mild Hepatic Fibrosis in Cholesterol and Sodium Cholate Diet-Fed Rats
Jeong, W., Jeong, D.-H., Sun-Hee, D. O., Kim, Y.-K., Park, H.-Y., Kwon, O.-D., Kim, T., & Jeong, K.-S. (2005) · Journal of Veterinary Medical Science · doi:10.1292/jvms.67.235 · Cited by 95
Endogenous liver carcinogenesis in the rat *
Nakae, D. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00990.x · Cited by 92
Leclercq (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000220 · Cited by 84
Salerno, A. G., SILVA, T. R. D., do Amaral, M. E. C., Alberici, L. C., Bonfleur, M. L., Patrício, P. R., Francesconi, E. P. M. S., Kassisse, D. M. G., Vercesi, A. E., Boschero, A. C., et al. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803646 · Cited by 53
A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits
Ogawa, T., Fujii, H., Yoshizato, K., & Kawada, N. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090895 · Cited by 48
Bie, J., Zhao, B., Song, J., & Ghosh, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069781 · Cited by 48
Browning, J. D., Cohen, J. C., & Hobbs, H. H. (2010) · Hepatology · doi:10.1002/hep.23946 · Cited by 39
Nakae, D., Mizumoto, Y., Andoh, N., Tamura, K., Horiguchi, K., Endoh, T., Kobayashi, E., Tsujiuchi, T., Denda, A., Lombardi, B., et al. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300504 · Cited by 36
Uji, Y., Yamamoto, H., Maeda, K., Tsuchihashi, H., Akabori, H., Shimizu, T., Endo, Y., Shimomura, I., & Tani, T. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.12.021 · Cited by 32
Cited by
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2300 · Cited by 554
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
Corbin, K. D., & Zeisel, S. H. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834e7b4b · Cited by 502
Metadata
- Authors
- Hebbard, L., & George, J.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2010-11-30
- Volume
- 8
- Issue
- 1
- Pages
- 35-44
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2035970641
- Cited by
- 499
- References
- 100
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.